Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites
暂无分享,去创建一个
C. Fishwick | K. El Bissati | C. Roberts | R. McLeod | S. Antonyuk | H. Lorenzi | C. Weber | Seungmin Hwang | R. Prud’homme | M. McPhillie | S. Muench | A. Sinai | G. Biagini | J. Lykins | Ying Zhou | Sarah Dovgin | Stuart Woods | H. Darby | J. Dubey | Qigui Li | M. Hickman | Zhu-Hong Li | James A Gordon | S. Moreno | K. Amporndanai | Kurt D. Ristroph | H. Cong | R. Priestley | Rachel M. Johnson | Scott B. Biering | F. Hakim | Kerrie E Hargrave | Patty J. Lee | Lucy Roberts | S. Biering
[1] Kristian E. Swearingen,et al. Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and mechanisms for liver-stage differentiation in relapsing malaria. , 2019, International journal for parasitology.
[2] G. Koh,et al. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. Reply. , 2019, The New England journal of medicine.
[3] W. Monteiro,et al. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria , 2019, The New England journal of medicine.
[4] Xiaocong Li,et al. Comparative studies of Toxoplasma gondii transcriptomes: insights into stage conversion based on gene expression profiling and alternative splicing , 2018, Parasites & Vectors.
[5] Shaun Rawson,et al. X-ray and cryo-EM structures of inhibitor-bound cytochrome bc 1 complexes for structure-based drug discovery , 2018, IUCrJ.
[6] W. de Souza,et al. Toxoplasma gondii reorganizes the host cell architecture during spontaneous cyst formation in vitro , 2017, Parasitology.
[7] R. F. Campbell,et al. Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria. , 2017, ACS infectious diseases.
[8] L. Hood,et al. Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer , 2017, Scientific Reports.
[9] Kristian E. Swearingen,et al. Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and potential mechanisms for liver-stage differentiation , 2017, bioRxiv.
[10] A. Biton,et al. Laser capture microdissection enables transcriptomic analysis of dividing and quiescent liver stages of Plasmodium relapsing species , 2017, Cellular microbiology.
[11] D. Agard,et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.
[12] J. Jakana,et al. Asymmetric cryo-EM structure of the canonical Allolevivirus Qβ reveals a single maturation protein and the genomic ssRNA in situ , 2016, Proceedings of the National Academy of Sciences.
[13] A. Rzhetsky,et al. Understanding Toxoplasmosis in the United States Through "Large Data" Analyses. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] L. Hood,et al. New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections , 2016, Scientific Reports.
[15] J. Rubio,et al. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial , 2016, Malaria Journal.
[16] A. Sinai,et al. Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo , 2015, mBio.
[17] David M. Shackleford,et al. ELQ-300 Prodrugs for Enhanced Delivery and Single-Dose Cure of Malaria , 2015, Antimicrobial Agents and Chemotherapy.
[18] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[19] S. Antonyuk,et al. Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1 , 2015, Proceedings of the National Academy of Sciences.
[20] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[21] Gary D Bader,et al. Biological Network Exploration with Cytoscape 3 , 2014, Current protocols in bioinformatics.
[22] Paul Theodor Pyl,et al. HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[23] Kami Kim,et al. Gene Set Enrichment Analysis (GSEA) of Toxoplasma gondii expression datasets links cell cycle progression and the bradyzoite developmental program , 2014, BMC Genomics.
[24] D. Caridha,et al. Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds , 2014, Malaria Journal.
[25] P. Mastroiacovo,et al. The global burden of congenital toxoplasmosis: a systematic review. , 2013, Bulletin of the World Health Organization.
[26] D. Caridha,et al. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6 , 2013, Malaria Journal.
[27] W. de Souza,et al. Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii. , 2013, Parasitology international.
[28] M. Abrahamowicz,et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] C. Roberts,et al. Salicylanilide inhibitors of Toxoplasma gondii. , 2012, Journal of medicinal chemistry.
[30] R. Yolken,et al. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis , 2012, Proceedings of the National Academy of Sciences.
[31] Garib N. Murshudov,et al. JLigand: a graphical tool for the CCP4 template-restraint library , 2012, Acta crystallographica. Section D, Biological crystallography.
[32] D. Rice,et al. Novel N-Benzoyl-2-Hydroxybenzamide Disrupts Unique Parasite Secretory Pathway , 2012, Antimicrobial Agents and Chemotherapy.
[33] Roman A. Laskowski,et al. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..
[34] R. McLeod,et al. Clinical Manifestations of Ocular Toxoplasmosis , 2011, Ocular immunology and inflammation.
[35] N. Pannu,et al. REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.
[36] Owen Johnson,et al. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.
[37] Philip R. Evans,et al. An introduction to data reduction: space-group determination, scaling and intensity statistics , 2011, Acta crystallographica. Section D, Biological crystallography.
[38] Michael S. Behnke,et al. T. gondii RP Promoters & Knockdown Reveal Molecular Pathways Associated with Proliferation and Cell-Cycle Arrest , 2010, PloS one.
[39] Annie F Kuo,et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. , 2008, American journal of ophthalmology.
[40] Peter G. Schultz,et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.
[41] L. Gerena,et al. Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening , 2007, Antimicrobial Agents and Chemotherapy.
[42] D. Rice,et al. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. , 2007 .
[43] D. Steindler,et al. Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain , 2006, Development.
[44] R. McLeod,et al. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. , 2006, The Pediatric infectious disease journal.
[45] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] W. Trager,et al. Human Malaria Parasites in Continuous Culture , 2005 .
[47] G. Brasseur,et al. Human Disease-related Mutations in Cytochrome b Studied in Yeast* , 2004, Journal of Biological Chemistry.
[48] Catherine Li,et al. High-Throughput Growth Assay for Toxoplasma gondii Using Yellow Fluorescent Protein , 2003, Antimicrobial Agents and Chemotherapy.
[49] A E Vercesi,et al. Respiration and Oxidative Phosphorylation in the Apicomplexan Parasite Toxoplasma gondii * , 1998, The Journal of Biological Chemistry.
[50] M. Nasr,et al. Two 2-Hydroxy-3-Alkyl-1,4-Naphthoquinones with In Vitro and In Vivo Activities against Toxoplasma gondii , 1998, Antimicrobial Agents and Chemotherapy.
[51] C. Katlama,et al. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] J. Major,et al. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives. , 1992, Journal of medicinal chemistry.
[53] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.
[54] S. Waxman,et al. Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow. , 1969, The New England journal of medicine.
[55] M. Steelman. Gene Set Enrichment Analysis (GSEA) , 2014 .
[56] Maja O’Connor,et al. A Longitudinal Study , 2013 .
[57] R. McLeod. Toxoplasmosis (Toxoplasma gondii) , 2011 .
[58] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[59] Nicholas Fisher,et al. Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays. , 2009, Methods in enzymology.
[60] S. Boudina,et al. Clinical manifestations of , 2009 .
[61] P. Afonine,et al. research papers Acta Crystallographica Section D Biological , 2003 .
[62] Július,et al. THE METABOLISM OF , 2003 .
[63] P. Vidigal,et al. Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. , 2002, Revista da Sociedade Brasileira de Medicina Tropical.
[64] M VALENTINCIC,et al. [Toxoplasma gondii]. , 1953, Zdravstveni vestnik.